The Risks of Splitting the MMR Vaccine: Historical Insights and Implications
Splitting the MMR vaccine could lead to missed doses and increased illness among children, echoing past lessons from vaccine history.
August 11, 2026
Lifestyle
Lifestyle trends and health tips
FDA Rejection Hits Radiopharma; Hims & Hers Eyes Peptides Market
FDA nixes a radiopharma drug by ITM Isotope Technologies, while Hims & Hers plans to enter the peptides market amidst evolving regulations.
August 11, 2026
Skylark Bio Launches Gene Therapy Trial Targeting GJB2-Related Deafness
Skylark Bio has initiated a clinical trial aimed at treating hearing loss in children with GJB2 mutations, following advancements in gene therapy.
August 11, 2026
The Shift in Abortion Care: A Move Towards Digital Support
Abortion care is evolving, with patients increasingly turning to digital solutions for reliable information and medical guidance.
August 11, 2026
Nurses Advocate for Involvement in Clinical AI Development Amid Growing Concerns
Nurses are increasingly spotlighting the risks of clinical AI, advocating for a collaborative approach to its development and deployment in healthcare.
August 11, 2026
FDA Denies Approval for ITM-11, a Radiopharmaceutical Therapy Set to Compete with Novartis
The FDA has rejected ITM-11 due to manufacturing concerns, hindering its potential as a competitor to Novartis’ treatment for rare neuroendocrine tumors.
August 10, 2026
New FDA Requirements on Food Additives Demand Transparency from Manufacturers
The FDA now requires manufacturers to disclose food additive details, enhancing oversight for substances previously lacking regulation.
August 10, 2026
Dissecting the Debate on Covid-19's Origins Amid Political Turmoil
The recent Senate hearings on Covid-19's origins spotlight political distractions, while China's suppression of information remains a pivotal issue.
August 07, 2026
NIH Decision Could Hinder International Researchers' Opportunities in Biomedical Fields
The NIH's proposed changes to funding eligibility may limit opportunities for international researchers on visas in the U.S. biomedical sector.
August 07, 2026
Replimune’s Melanoma Drug Approved Amid Medicare Policy Shift Impacting Price Negotiations
Replimune's new melanoma treatment gains FDA approval, while a Medicare policy change delays price negotiations for AbbVie drugs.
August 07, 2026
Replimune's Tumultuous Journey Ends with FDA Approval of Melanoma Treatment
Replimune's advanced melanoma drug, RP1, receives FDA approval after a challenging path, bringing hope to patients with a hefty price tag.
August 06, 2026
Medicare's Policy Shift Delays Price Negotiations for Key AbbVie Drug
A recent Medicare policy change has postponed the price negotiations for a major AbbVie drug, potentially impacting taxpayers significantly.
August 06, 2026
FDA Approval of Takeda's Orzeyful Marks a Shift in Narcolepsy Treatment
The FDA has approved Takeda's Orzeyful, a new orexin receptor agonist that promises to improve daytime alertness for narcolepsy patients.
August 05, 2026
Federal Regulators Engage with Tech Giants to Shape Clinical AI Policies
Federal health officials convene with major tech firms to discuss the future of clinical AI, aiming for safe implementation and regulatory clarity.
August 05, 2026
Fecal Microbiome Transplants Show Promise for Treating Peanut Allergies
A clinical trial indicates potential for fecal microbiome transplants to improve peanut allergy tolerance, exciting experts in the field.
August 05, 2026
Reassessing AI Potential: Insights from Schrödinger’s CEO Ramy Farid
Ramy Farid of Schrödinger reflects on the evolving role of AI in biotech, envisioning clearer perceptions in the industry within five years.
August 05, 2026
Medicaid's New Toolkit for Autism Therapy: Shifting Oversight in Behavior Analysis
A new Medicaid toolkit emphasizes stricter oversight and measurable outcomes for autism therapies, raising concerns around ABA services and telehealth.
August 05, 2026
Navigating the Challenges of Limb Girdle Muscular Dystrophy Treatment Development
As advancements accelerate in rare disease therapies, LGMD patients face urgency, with time impacting their muscle function and access to new treatments.
July 31, 2026
Examining the Misinterpretations in Recent Covid Research Critiques
Recent critiques of a Covid study misrepresent key findings and overlook significant challenges in assessing nonpharmaceutical interventions' impacts.
July 31, 2026
Rising Oil Prices and Their Impact on Medicine Manufacturing Costs
Increased oil prices may significantly hike the cost of certain medicines, highlighting the need to reduce reliance on petrochemicals for production.
July 30, 2026